Patzke, C. L., & Emadi, A. (2020). High dose cytarabine, mitoxantrone, pegasapargase (HAM-pegA) in combination with dasatinib for the first-line treatment of Philadelphia chromosome positive mixed phenotype acute leukemia. Am J Leuk Res.
Citación estilo ChicagoPatzke, Ciera L., and Ashkan Emadi. "High Dose Cytarabine, Mitoxantrone, Pegasapargase (HAM-pegA) in Combination With Dasatinib for the First-line Treatment of Philadelphia Chromosome Positive Mixed Phenotype Acute Leukemia." Am J Leuk Res 2020.
Cita MLAPatzke, Ciera L., and Ashkan Emadi. "High Dose Cytarabine, Mitoxantrone, Pegasapargase (HAM-pegA) in Combination With Dasatinib for the First-line Treatment of Philadelphia Chromosome Positive Mixed Phenotype Acute Leukemia." Am J Leuk Res 2020.